Researchers have successfully modified the AlphaFold AI protein-folding software to identify and redesign specific regions of gene-editing proteins, significantly reducing off-target effects. This advancement addresses a critical safety hurdle in CRISPR therapies by minimizing unintended DNA edits caused by the large size of the human genome. The study, published in Nature, demonstrates a new paradigm for enhancing the precision of genetic engineering tools.
Background
CRISPR-Cas9 and related gene-editing technologies face ongoing challenges with off-target effects, where the system inadvertently edits incorrect DNA sequences. Improving specificity is essential for the clinical viability and safety of gene therapies.
- Source
- Ars Technica
- Published
- Jul 25, 2026 at 01:31 AM
- Score
- 8.0 / 10